CROWN HOLDINGS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CROWN HOLDINGS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $2.79B | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $3.08B | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $3.04B | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $2.76B | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $2.73B | Feb 28, 2020 |
| FY2019 | Sep 30, 2018 | $3.17B | Feb 28, 2020 |
| FY2019 | Jun 30, 2018 | $3.05B | Feb 28, 2020 |
| FY2019 | Mar 31, 2018 | $2.20B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $2.17B | Feb 28, 2019 |
| FY2018 | Sep 30, 2017 | $2.47B | Feb 28, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.37B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $11.80B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $12.01B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $12.94B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $11.39B | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | $2.96B | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $3.17B | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $2.69B | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $2.76B | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $2.79B | Feb 26, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $8.70B | Feb 26, 2018 |
| FY2017 | Dec 31, 2016 | $8.28B | Feb 26, 2018 |
| FY2017 | Dec 31, 2015 | $8.76B | Feb 26, 2018 |
| FY2016 | Dec 31, 2014 | $9.10B | Feb 24, 2017 |
| FY2015 | Dec 31, 2013 | $8.66B | Feb 29, 2016 |
| FY2012 | Dec 31, 2012 | $2.04B | Mar 1, 2013 |
| FY2012 | Sep 30, 2012 | $2.30B | Mar 1, 2013 |
| FY2012 | Jun 30, 2012 | $2.18B | Mar 1, 2013 |
| FY2012 | Mar 31, 2012 | $1.95B | Mar 1, 2013 |
| FY2012 | Dec 31, 2011 | $2.06B | Mar 1, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $512.00M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $568.00M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $417.00M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $415.00M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $400.00M | Feb 26, 2021 |
| FY2020 | Sep 30, 2019 | $508.00M | Feb 26, 2021 |
| FY2020 | Jun 30, 2019 | $495.00M | Feb 26, 2021 |
| FY2020 | Mar 31, 2019 | $423.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $390.00M | Feb 28, 2020 |
| FY2019 | Sep 30, 2018 | $517.00M | Feb 28, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $738.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $424.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $450.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $727.00M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($560.00M) | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | $151.00M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $214.00M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $126.00M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $88.00M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $87.00M | Feb 26, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.55B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.42B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.27B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.34B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.36B | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | $337.00M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $406.00M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $275.00M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $246.00M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $199.00M | Feb 26, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $32.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $33.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $34.00M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $47.00M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $48.00M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $50.00M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $51.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $39.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $41.00M | Feb 28, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $632.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $597.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $582.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $556.00M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $583.00M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $533.00M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $556.00M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $558.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $367.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $366.00M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.53B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.19B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.45B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $803.00M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $905.00M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $1.32B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.16B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $571.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | ($251.00M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | ($134.00M) | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $413.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $403.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $793.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $839.00M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $816.00M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $554.00M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $391.00M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $462.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $498.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $473.00M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.27B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $13.85B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $15.03B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $14.30B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $13.86B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $16.69B | Feb 28, 2022 |
| FY2021 | Dec 31, 2019 | $12.72B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $15.26B | Feb 26, 2021 |
| FY2018 | Jan 1, 2018 | $10.70B | Feb 28, 2019 |
| FY2019 | Dec 31, 2017 | $10.66B | Feb 28, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.00B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.76B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.41B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.85B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $1.91B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $2.20B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.71B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $937.00M | Feb 28, 2020 |
| FY2018 | Jan 1, 2018 | $610.00M | Feb 28, 2019 |
| FY2018 | Dec 31, 2017 | $601.00M | Feb 28, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.16B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.95B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $3.12B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $2.95B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $3.01B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $3.15B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $3.09B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $4.44B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $3.05B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $2.79B | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.81B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.62B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $3.48B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $3.14B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $3.18B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $4.54B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $3.96B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $3.45B | Feb 28, 2020 |
| FY2018 | Jan 1, 2018 | $3.01B | Feb 28, 2019 |
| FY2018 | Dec 31, 2017 | $3.00B | Feb 28, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $764.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $918.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.31B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $550.00M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $531.00M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $1.17B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $607.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $607.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $424.00M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $559.00M | Feb 26, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.88B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $6.14B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $7.46B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $6.90B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $6.19B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $8.09B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $7.88B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $8.57B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $5.28B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $4.88B | Feb 26, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | (4) | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 26, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | (4) | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 26, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 113.42M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 118.50M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 120.64M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | 119.95M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | 126.13M | Mar 3, 2025 |
| FY2023 | Dec 31, 2020 | 134.80M | Feb 27, 2024 |
| FY2022 | Dec 31, 2019 | 135.58M | Feb 27, 2023 |
| FY2021 | Dec 31, 2018 | 135.17M | Feb 28, 2022 |
| FY2020 | Dec 31, 2017 | 134.28M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | 139.84M | Feb 28, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $120.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $119.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $115.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $106.00M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $105.00M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $0 | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $0 | Feb 28, 2022 |